Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the seasonal influenza vaccine market such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook, and sales analysis of seasonal influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:

United States

United Kingdom

France

Italy

Spain

Germany

Japan

Major and Promising Vaccines covered in the report are as follows:

Fluzone High–Dose

Fluzone Quadrivalent

Intradermal (ID) Trivalent

Vaxigrip

Fluarix Quadrivalent

Flulaval Quadrivalent

Fluenz Tetra

FluMist Quadrivalent

Flublok

VN–100

M–001

VAX–2012Q

TAK – 850

Flucelvax Quadrivalent

Afluria Quadrivalent

Agrippal

Fluad

Fluvirin

Fluvax

Seasonal Influenza Vaccine Report is segmented with 10 Chapters:

Chapter 1: Chapter one is the introduction with Executive Summary

Chapter 2: Chapter two provides overall recent and forecasts data for the seasonal influenza vaccine market in the top seven countries. This Chapter divided into 4 parts

1. Overall seasonal influenza vaccine market data from 2010 to 2022

2. Overall number of persons vaccinated with seasonal influenza vaccine data from 2010 to 2022

3. Seasonal influenza vaccine market share in the top seven countries data from 2010 to 2022

4. Persons being vaccinated with influenza vaccine share in the top seven countries data from 2010 to 2022

Chapter 4: Chapter four gives detailed recent and forecasts for the seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated, number of pregnant women vaccinated, number of chronic medical condition persons vaccinated, number of healthcare workers vaccinated and vaccination coverage.

Chapter 6: Chapter six offers information about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU and Japan.

Chapter 7: Chapter seven highlights key M&A deals that took place in the seasonal influenza vaccine market between 2003 and 2015 and lists the major collaborations, licensing, exclusive and distribution agreements deals.

Chapter 8: Chapter eight provides detailed pipeline influenza vaccines in various companies’ pipelines with clinical development and early stage development vaccines.

4. Seasonal Influenza Vaccine Market in Top Seven Countries – Geographical Landscape4.1 United States4.1.1 Seasonal Influenza Vaccine Market4.1.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.1.2.1 Number of Children Vaccinated4.1.2.2 Number of Adults Vaccinated4.2 Germany4.2.1 Seasonal Influenza Vaccine Market4.2.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.2.2.1 Number of 60+ Years of Age Persons Vaccinated4.2.2.2 Number of Pregnant Women Vaccinated4.2.2.3 Number of Chronic Medical Condition Persons Vaccinated4.2.2.4 Number of Healthcare Workers Vaccinated4.3 France4.3.1 Seasonal Influenza Vaccine Market4.3.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.3.2.1 Number of 65+ Years of Age Persons Vaccinated4.3.2.2 Number of Pregnant Women Vaccinated4.3.2.3 Number of Chronic Medical Condition Persons Vaccinated4.3.2.4 Number of Healthcare Workers Vaccinated4.4 Italy4.4.1 Seasonal Influenza Vaccine Market4.4.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.4.2.1 Number of 65+ Years of Age Persons Vaccinated4.4.2.2 Number of Pregnant Women Vaccinated4.4.2.3 Number of Chronic Medical Condition Persons Vaccinated4.4.2.4 Number of Healthcare Workers Vaccinated4.5 United Kingdom4.5.1 Seasonal Influenza Vaccine Market4.5.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.5.2.1 Number of Children Vaccinated4.5.2.2 Number of 65+ Years of Age Persons Vaccinated4.5.2.3 Number of Pregnant Women Vaccinated4.5.2.4 Number of Chronic Medical Condition Persons Vaccinated4.5.2.5 Number of Healthcare Workers Vaccinated4.6 Spain4.6.1 Seasonal Influenza Vaccine Market4.6.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.6.2.1 Number of 65+ Years of Age Persons Vaccinated4.6.2.2 Number of Pregnant Women Vaccinated4.6.2.3 Number of Chronic Medical Condition Persons Vaccinated4.6.2.4 Number of Healthcare Workers Vaccinated4.7 Japan4.7.1 Seasonal Influenza Vaccine Market4.7.2 Total – Number of Persons Vaccinated with Seasonal Influenza Vaccine4.7.2.1 Number of Children Vaccinated4.7.2.2 Number of 65+ Years of Age Persons Vaccinated4.7.2.3 Number of Pregnant Women Vaccinated4.7.2.4 Number of Chronic Medical Condition Persons Vaccinated4.7.2.5 Number of Healthcare Workers Vaccinated

6. Seasonal Influenza Vaccine Market – Regulatory Landscape6.1 Registration Process and Regulations for Vaccine in the US6.2 Registration Process and Regulations for Vaccine in the EU6.3 Registration Process and Regulations for Vaccine in Japan

Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and well share relevant market report titles for you to explore.

"Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease"
Scope of th...

The global Epidermal Growth Factor (EGF) market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with ma...

The global Electroceuticals Medicine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with market...

The global Clozapine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with market size of xx mill...

The global Chitosan Gel market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with market size of xx m...

The global Andrographis Paniculata Extract market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with ...

In this report, the United States Topiramate market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United State...

In this report, the United States Lincomycin Hydrochloride market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits th...

In this report, the United States Ceramic Bone Cement market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the Uni...

In this report, the United States Monoclonal Antibody Diagnostic Reagents market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this r...

Research Support / Custom Research

If this business study does not have the data and information analysis you need,
contact us with your research requirements. We explore available market research
reports to map your needs and share report titles with you. Alternatively, we can
also offer custom research that suits your budget and timelines. Share your information
requirements here.

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.